DAWEX
22.4.2024 08:31:26 CEST | Business Wire | Press release
Data4Industry-X, the trusted data exchange solution for Industry, carries on its dynamics to bring the most comprehensive and flexible solution on the market for industrial organizations aiming at boosting competitiveness and minimizing carbon footprint. Recognized as a Gaia-X Lighthouse project and contributing to the Manufacturing-X initiative, the Data4Industry-X solution is designed to accelerate data & information exchange between global organizations, subsidiaries and suppliers by leveraging the most advanced, secure and compliant data exchange technology on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240421440918/en/
Supported by the AIF (Alliance pour l’industrie du futur), and initially responding to the power generation and automotive markets, Data4Industry-X gathers technological & industrial expertise from Dawex, Schneider Electric, Valeo, CEA, and Prosyst, in order to deliver broad cross-border, cross-company, cross-factory industrial data exchanges.
Industrial organizations with plants, shop floors and suppliers, spread across the globe with decentralized manufacturing, are concerned by their ability to bring innovations and operational efficiencies to increase competitiveness, while reducing CO2 emissions to meet and report on their sustainability obligations.
With the objective to support the digital transformation of all industry stakeholders and create a compelling industry data ecosystem encompassing all sizes of organizations, Data4Industry-X solution relies on Dawex Data Exchange technology. The solution is based on open and cloud-agnostic architecture, to deliver a trusted, secure, sovereign and compliant data exchange environment that implements the Gaia-X de facto standards. Powered by this technology, the Data4Industry-X solution will use the Eclipse Dataspace Component framework to facilitate interoperability between data spaces. Additionally, thanks to the UDC (Unified Data Collector) Prosyst solution, Data4Industry-X interfaces with OPC UA protocol to retrieve industrial data and exchange them at scale with the broad ecosystem.
By relying on technological and industrial expertise, Data4Industry-X becomes the most agnostic, flexible and advanced data exchange solution for Industry, designed in compliance with the new European data regulations, such as the Data Act and the Data Governance Act, capable of operating in any industrial situation, with all types of companies.
The Data4Industry-X solution will bridge the entire industry data ecosystem by enabling large and small organizations in all sectors to exchange, distribute and valorize industrial data, securely, to ultimately improve operational efficiency and meet decarbonation objectives.
“Data4Industry-X pursues its dynamics to deploy the most advanced data exchange solution for the industry to accelerate innovation, better control carbon footprint, and gain competitive advantage thanks to data circulation.” said Laurent Lafaye, co-CEO at Dawex. “Data4Industry-X will ultimately empower all industry stakeholders, of all sizes, to engage into data exchange and contribute to fostering a resilient and sustainable industry ecosystem by benefiting from the full potential of data”.
Data4Industry-X is supported by the French government’s France 2030 initiative and the European program Next Generation.
About Dawex
About Schneider Electric
About Valeo
About CEA-List
About Prosyst
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240421440918/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom